{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:48:57Z","timestamp":1790628537970,"version":"4.1.0"},"reference-count":146,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuromol Med"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s12017-019-08583-1","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T20:03:25Z","timestamp":1575489805000},"page":"194-209","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["ACE-Triggered Hypertension Incites Stroke: Genetic, Molecular, and Therapeutic Aspects"],"prefix":"10.1007","volume":"22","author":[{"given":"Kanika","family":"Vasudeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renuka","family":"Balyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7657-8592","authenticated-orcid":false,"given":"Anjana","family":"Munshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,4]]},"reference":[{"issue":"15","key":"8583_CR1","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.2174\/138161209788186290","volume":"15","author":"MY Abeywardena","year":"2009","unstructured":"Abeywardena, M. Y., Leifert, W. R., Warnes, K. E., Varghese, J. N., & Head, R. J. (2009). Cardiovascular biology of interleukin-6. Current Pharmaceutical Design,15(15), 1809\u20131821.","journal-title":"Current Pharmaceutical Design"},{"issue":"4","key":"8583_CR2","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/bph.12177","volume":"169","author":"D Agarwal","year":"2013","unstructured":"Agarwal, D., Dange, R. B., Raizada, M. K., & Francis, J. (2013). Angiotensin II causes imbalance between pro-and anti-inflammatory cytokines by modulating GSK-3\u03b2 in neuronal culture. British Journal of Pharmacology,169(4), 860\u2013874.","journal-title":"British Journal of Pharmacology"},{"issue":"2","key":"8583_CR3","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1161\/hy0202.104272","volume":"39","author":"AM Allen","year":"2002","unstructured":"Allen, A. M. (2002). Inhibition of the hypothalamic paraventricular nucleus in spontaneously hypertensive rats dramatically reduces sympathetic vasomotor tone. Hypertension,39(2), 275\u2013280.","journal-title":"Hypertension"},{"key":"8583_CR4","doi-asserted-by":"crossref","unstructured":"Arnold, J. M. O., Yusuf, S., Young, J., Mathew, J., Johnstone, D., Avezum, A., \u2026 Bosch, J. (2003). Prevention of heart failure in patients in the Heart Outcomes Prevention Evaluation (HOPE) study. Circulation, 107(9), 1284\u20131290.","DOI":"10.1161\/01.CIR.0000054165.93055.42"},{"issue":"15","key":"8583_CR5","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","volume":"336","author":"PJ Barnes","year":"1997","unstructured":"Barnes, P. J., & Karin, M. (1997). Nuclear factor-\u03baB\u2014A pivotal transcription factor in chronic inflammatory diseases. New England Journal of Medicine,336(15), 1066\u20131071.","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"8583_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11906-011-0235-6","volume":"14","author":"S B\u00e1tkai","year":"2012","unstructured":"B\u00e1tkai, S., & Thum, T. (2012). MicroRNAs in hypertension: Mechanisms and therapeutic targets. Current Hypertension Reports,14(1), 79\u201387.","journal-title":"Current Hypertension Reports"},{"key":"8583_CR7","doi-asserted-by":"crossref","unstructured":"Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., \u2026 Isasi, C. (2017). Heart disease and stroke statistics-2017 update: A report from the American Heart Association. Circulation, 135(10), e146\u2013e603.","DOI":"10.1161\/CIR.0000000000000485"},{"key":"8583_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.phrs.2017.03.017","volume":"120","author":"VC Biancardi","year":"2017","unstructured":"Biancardi, V. C., Bomfim, G. F., Reis, W. L., Al-Gassimi, S., & Nunes, K. P. (2017). The interplay between Angiotensin II, TLR4 and hypertension. Pharmacological Research,120, 88\u201396.","journal-title":"Pharmacological Research"},{"issue":"9","key":"8583_CR9","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1172\/JCI38864","volume":"119","author":"T Boettger","year":"2009","unstructured":"Boettger, T., Beetz, N., Kostin, S., Schneider, J., Kr\u00fcger, M., Hein, L., et al. (2009). Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143\/145 gene cluster. The Journal of Clinical Investigation,119(9), 2634\u20132647.","journal-title":"The Journal of Clinical Investigation"},{"key":"8583_CR10","doi-asserted-by":"crossref","unstructured":"B\u00f6hm, M., Schumacher, H., Teo, K. K., Lonn, E. M., Mahfoud, F., Mann, J. F., \u2026 Sliwa, K. (2017). Achieved blood pressure and cardiovascular outcomes in high-risk patients: Results from ONTARGET and TRANSCEND trials. The Lancet, 389(10085), 2226\u20132237.","DOI":"10.1016\/S0140-6736(17)30754-7"},{"issue":"6","key":"8583_CR11","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.tins.2017.04.001","volume":"40","author":"HD Booth","year":"2017","unstructured":"Booth, H. D., Hirst, W. D., & Wade-Martins, R. (2017). The role of astrocyte dysfunction in Parkinson\u2019s disease pathogenesis. Trends in Neurosciences,40(6), 358\u2013370.","journal-title":"Trends in Neurosciences"},{"issue":"9","key":"8583_CR12","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1590\/S0100-879X2011007500088","volume":"44","author":"V Braga","year":"2011","unstructured":"Braga, V., Medeiros, I., Ribeiro, T., Fran\u00e7a-Silva, M., Botelho-Ono, M., & Guimar\u00e3es, D. (2011). Angiotensin-II-induced reactive oxygen species along the SFO-PVN-RVLM pathway: Implications in neurogenic hypertension. Brazilian Journal of Medical and Biological Research,44(9), 871\u2013876.","journal-title":"Brazilian Journal of Medical and Biological Research"},{"issue":"1","key":"8583_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4161\/pri.22512","volume":"7","author":"L Brambilla","year":"2013","unstructured":"Brambilla, L., Martorana, F., & Rossi, D. (2013). Astrocyte signaling and neurodegeneration: New insights into CNS disorders. Prion,7(1), 28\u201336.","journal-title":"Prion"},{"issue":"3","key":"8583_CR14","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1161\/01.HYP.0000179088.57586.26","volume":"46","author":"VM Campese","year":"2005","unstructured":"Campese, V. M., Shaohua, Y., & Huiquin, Z. (2005). Oxidative stress mediates angiotensin II\u2013dependent stimulation of sympathetic nerve activity. Hypertension,46(3), 533\u2013539.","journal-title":"Hypertension"},{"issue":"1","key":"8583_CR15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1161\/HYPERTENSIONAHA.111.182154","volume":"59","author":"JP Cardinale","year":"2012","unstructured":"Cardinale, J. P., Sriramula, S., Mariappan, N., Agarwal, D., & Francis, J. (2012). Angiotensin II\u2013induced hypertension is modulated by nuclear factor-\u03baB in the paraventricular nucleus. Hypertension,59(1), 113\u2013121.","journal-title":"Hypertension"},{"issue":"5","key":"8583_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11906-015-0550-4","volume":"17","author":"CY Carmichael","year":"2015","unstructured":"Carmichael, C. Y., & Wainford, R. D. (2015). Hypothalamic signaling mechanisms in hypertension. Current Hypertension Reports,17(5), 39.","journal-title":"Current Hypertension Reports"},{"key":"8583_CR17","doi-asserted-by":"crossref","unstructured":"Castoldi, G., Di Gioia, C. R., Bombardi, C., Catalucci, D., Corradi, B., Gualazzi, M. G., \u2026 Condorelli, G. (2012). MiR-133a regulates collagen 1A1: Potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension. Journal of cellular physiology, 227(2), 850\u2013856.","DOI":"10.1002\/jcp.22939"},{"key":"8583_CR18","doi-asserted-by":"crossref","unstructured":"Castoldi, G., di Gioia, C., Giollo, F., Carletti, R., Bombardi, C., Antoniotti, M., \u2026 Stella, A. (2016). Different regulation of miR-29a-3p in glomeruli and tubules in an experimental model of angiotensin II-dependent hypertension: Potential role in renal fibrosis. Clinical and Experimental Pharmacology and Physiology, 43(3), 335\u2013342.","DOI":"10.1111\/1440-1681.12532"},{"issue":"4","key":"8583_CR19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1177\/1076029608315163","volume":"15","author":"G Celiker","year":"2009","unstructured":"Celiker, G., Can, U., Verdi, H., Yazici, A. C., Ozbek, N., & Atac, F. B. (2009). Prevalence of thrombophilic mutations and ACE I\/D polymorphism in Turkish ischemic stroke patients. Clinical and Applied Thrombosis\/Hemostasis,15(4), 415\u2013420.","journal-title":"Clinical and Applied Thrombosis\/Hemostasis"},{"key":"8583_CR20","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1097\/00004872-200306005-00003","volume":"21","author":"J Chalmers","year":"2003","unstructured":"Chalmers, J., & MacMahon, S. (2003). Perindopril protection against Recurrent Stroke Study (PROGRESS): Interpretation and implementation. Journal of Hypertension,21, S9\u2013S14.","journal-title":"Journal of Hypertension"},{"issue":"5","key":"8583_CR21","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1161\/01.HYP.32.5.939","volume":"32","author":"JY Chan","year":"1998","unstructured":"Chan, J. Y., Chen, W.-C., Lee, H.-Y., & Chan, S. H. (1998). Elevated Fos expression in the nucleus tractus solitarii is associated with reduced baroreflex response in spontaneously hypertensive rats. Hypertension,32(5), 939\u2013944.","journal-title":"Hypertension"},{"issue":"12","key":"8583_CR22","doi-asserted-by":"publisher","first-page":"3879","DOI":"10.3390\/ijms19123879","volume":"19","author":"Y-C Chen","year":"2018","unstructured":"Chen, Y.-C., Chang, K.-H., & Chen, C.-M. (2018). Genetic polymorphisms associated with spontaneous intracerebral hemorrhage. International Journal of Molecular Sciences,19(12), 3879.","journal-title":"International Journal of Molecular Sciences"},{"issue":"10","key":"8583_CR23","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1006\/jmcc.2000.1215","volume":"32","author":"MM Chen","year":"2000","unstructured":"Chen, M. M., Lam, A., Abraham, J. A., Schreiner, G. F., & Joly, A. H. (2000). CTGF expression is induced by TGF-\u03b2 in cardiac fibroblasts and cardiac myocytes: A potential role in heart fibrosis. Journal of Molecular and Cellular Cardiology,32(10), 1805\u20131819.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"4","key":"8583_CR24","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1161\/CIRCRESAHA.109.208439","volume":"106","author":"W-H Cheng","year":"2010","unstructured":"Cheng, W.-H., Lu, P.-J., Ho, W.-Y., Tung, C.-S., Cheng, P.-W., Hsiao, M., et al. (2010). Angiotensin II inhibits neuronal nitric oxide synthase activation through the ERK1\/2-RSK signaling pathway to modulate central control of blood pressure. Circulation Research,106(4), 788.","journal-title":"Circulation Research"},{"key":"8583_CR25","first-page":"106","volume":"1","author":"L Chengzhi","year":"2012","unstructured":"Chengzhi, L., Li, W., Essackjee, A., Sherpa, N., & Di, L. (2012). Angiotensin-II induced reactive oxygen species: Implications in neurogenic hypertension. Journal of Hypertension,1, 106.","journal-title":"Journal of Hypertension"},{"issue":"1\u20133","key":"8583_CR26","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.regpep.2007.07.001","volume":"144","author":"MA Clark","year":"2007","unstructured":"Clark, M. A., & Gonzalez, N. (2007a). Angiotensin II stimulates rat astrocyte mitogen-activated protein kinase activity and growth through EGF and PDGF receptor transactivation. Regulatory Peptides,144(1\u20133), 115\u2013122.","journal-title":"Regulatory Peptides"},{"issue":"1\u20133","key":"8583_CR27","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.regpep.2007.02.008","volume":"143","author":"MA Clark","year":"2007","unstructured":"Clark, M. A., & Gonzalez, N. (2007b). Src and Pyk2 mediate angiotensin II effects in cultured rat astrocytes. Regulatory Peptides,143(1\u20133), 47\u201355.","journal-title":"Regulatory Peptides"},{"issue":"1","key":"8583_CR28","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.brainresbull.2007.07.028","volume":"75","author":"MA Clark","year":"2008","unstructured":"Clark, M. A., Guillaume, G., & Pierre-Louis, H. C. (2008). Angiotensin II induces proliferation of cultured rat astrocytes through c-Jun N-terminal kinase. Brain Research Bulletin,75(1), 101\u2013106.","journal-title":"Brain Research Bulletin"},{"key":"8583_CR29","unstructured":"Clark, M., Landrum, M., & Tallant, E. (2001). Angiotensin II activates mitogen-activated protein kinases and stimulates growth in rat medullary astrocytes. Paper Presented at the Faseb Journal."},{"key":"8583_CR30","unstructured":"Dahl\u00f6f, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., \u2026 Lederballe-Pedersen, O. (2002). Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol. The Lancet, 359(9311), 995\u20131003."},{"key":"8583_CR31","doi-asserted-by":"crossref","unstructured":"Dardiotis, E., Jagiella, J., Xiromerisiou, G., Dardioti, M., Vogiatzi, C., Urbanik, A., \u2026 Slowik, A. (2011). Angiotensin-converting enzyme tag single nucleotide polymorphisms in patients with intracerebral hemorrhage. Pharmacogenetics and Genomics, 21(3), 136\u2013141.","DOI":"10.1097\/FPC.0b013e328343ab15"},{"issue":"1","key":"8583_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10072-014-1880-8","volume":"36","author":"S Das","year":"2015","unstructured":"Das, S., Roy, S., Sharma, V., Kaul, S., Jyothy, A., & Munshi, A. (2015). Association of ACE gene I\/D polymorphism and ACE levels with hemorrhagic stroke: Comparison with ischemic stroke. Neurological Sciences,36(1), 137\u2013142.","journal-title":"Neurological Sciences"},{"issue":"6565","key":"8583_CR33","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/379557a0","volume":"379","author":"H Daub","year":"1996","unstructured":"Daub, H., Weiss, F. U., Wallasch, C., & Ullrich, A. (1996). Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature,379(6565), 557.","journal-title":"Nature"},{"issue":"3","key":"8583_CR34","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s11064-007-9474-y","volume":"33","author":"J Delaney","year":"2008","unstructured":"Delaney, J., Chiarello, R., Villar, D., Kandalam, U., Castejon, A. M., & Clark, M. A. (2008). Regulation of c-fos, c-jun and c-myc gene expression by angiotensin II in primary cultured rat astrocytes: Role of ERK1\/2 MAP kinases. Neurochemical Research,33(3), 545\u2013550.","journal-title":"Neurochemical Research"},{"key":"8583_CR35","volume-title":"A haplotype analysis of the angiotensin converting enzyme gene in ischaemic stroke","author":"GJ Dennis","year":"2008","unstructured":"Dennis, G. J. (2008). A haplotype analysis of the angiotensin converting enzyme gene in ischaemic stroke. Leicester: University of Leicester."},{"issue":"35","key":"8583_CR36","doi-asserted-by":"publisher","first-page":"E2334","DOI":"10.1073\/pnas.1209577109","volume":"109","author":"C Di Malta","year":"2012","unstructured":"Di Malta, C., Fryer, J. D., Settembre, C., & Ballabio, A. (2012). Astrocyte dysfunction triggers neurodegeneration in a lysosomal storage disorder. Proceedings of the National Academy of Sciences USA,109(35), E2334\u2013E2342.","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"8583_CR37","doi-asserted-by":"crossref","unstructured":"Dive, V., Cotton, J., Yiotakis, A., Michaud, A., Vassiliou, S., Jiracek, J., \u2026 Corvol, P. (1999). RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites. Proceedings of the National Academy of Sciences USA, 96(8), 4330\u20134335.","DOI":"10.1073\/pnas.96.8.4330"},{"key":"8583_CR38","doi-asserted-by":"crossref","unstructured":"Domingues-Montanari, S., Fernandez-Cadenas, I., Del Rio-Espinola, A., Mendioroz, M., Ribo, M., Obach, V., \u2026 Corbeto, N. (2010). The I\/D polymorphism of the ACE1 gene is not associated with ischaemic stroke in Spanish individuals. European Journal of Neurology, 17(11), 1390\u20131392.","DOI":"10.1111\/j.1468-1331.2010.03022.x"},{"key":"8583_CR39","doi-asserted-by":"crossref","unstructured":"Domingues-Montanari, S., Hernandez-Guillamon, M., Fernandez-Cadenas, I., Mendioroz, M., Boada, M., Munuera, J., \u2026 Gutierrez, M. (2011). ACE variants and risk of intracerebral hemorrhage recurrence in amyloid angiopathy. Neurobiology of Aging, 32(3), 551. e513\u2013551. e522.","DOI":"10.1016\/j.neurobiolaging.2010.01.019"},{"issue":"1\u20133","key":"8583_CR40","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0167-0115(00)00126-9","volume":"91","author":"S Eguchi","year":"2000","unstructured":"Eguchi, S., & Inagami, T. (2000). Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase. Regulatory Peptides,91(1\u20133), 13\u201320.","journal-title":"Regulatory Peptides"},{"key":"8583_CR41","doi-asserted-by":"crossref","unstructured":"Eskildsen, T., Jeppesen, P., Schneider, M., Nossent, A., Sandberg, M., Hansen, P., \u2026 Rasmussen, L. (2013). Angiotensin II regulates microRNA-132\/-212 in hypertensive rats and humans. International Journal of Molecular Sciences, 14(6), 11190\u201311207.","DOI":"10.3390\/ijms140611190"},{"key":"8583_CR42","doi-asserted-by":"crossref","unstructured":"Fernandes, T., Hashimoto, N. Y., Magalhaes, F. C., Fernandes, F. B., Casarini, D. E., Carmona, A. K., \u2026 Oliveira, E. M. (2011). Aerobic exercise training\u2013induced left ventricular hypertrophy involves regulatory MicroRNAs, decreased angiotensin-converting enzyme-angiotensin II, and synergistic regulation of angiotensin-converting enzyme 2-angiotensin (1-7). Hypertension, 58(2), 182\u2013189.","DOI":"10.1161\/HYPERTENSIONAHA.110.168252"},{"key":"8583_CR43","first-page":"71","volume":"9","author":"R Ferrari","year":"2004","unstructured":"Ferrari, R. (2004). Preserving bradykinin or blocking angiotensin II: The cardiovascular dilemma. Dialogues in Cardiovascular Medicine,9, 71\u201392.","journal-title":"Dialogues in Cardiovascular Medicine"},{"issue":"S1","key":"8583_CR44","doi-asserted-by":"publisher","first-page":"9S","DOI":"10.1016\/S0895-7061(01)02274-9","volume":"15","author":"CM Ferrario","year":"2002","unstructured":"Ferrario, C. M. (2002). Use of angiotensin II receptor blockers in animal models of atherosclerosis. American Journal of Hypertension,15(S1), 9S\u201313S.","journal-title":"American Journal of Hypertension"},{"issue":"1","key":"8583_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MNH.0b013e3283406f57","volume":"20","author":"CM Ferrario","year":"2011","unstructured":"Ferrario, C. M. (2011). ACE 2: More of Ang 1-7 or less Ang II? Current Opinion in Nephrology and Hypertension,20(1), 1.","journal-title":"Current Opinion in Nephrology and Hypertension"},{"issue":"5","key":"8583_CR46","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1042\/cs1000481","volume":"100","author":"AG Frauman","year":"2001","unstructured":"Frauman, A. G., Johnston, C. I., & Fabiani, M. E. (2001). Angiotensin receptors: Distribution, signalling and function. Clinical Science,100(5), 481\u2013492.","journal-title":"Clinical Science"},{"issue":"2","key":"8583_CR47","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1159\/000355429","volume":"127","author":"S Gao","year":"2014","unstructured":"Gao, S., Liu, T.-W., Wang, Z., Jiao, Z.-Y., Cai, J., Chi, H.-J., et al. (2014). Downregulation of MicroRNA-19b contributes to angiotensin II-induced overexpression of connective tissue growth factor in cardiomyocytes. Cardiology,127(2), 114\u2013120.","journal-title":"Cardiology"},{"issue":"2\u20133","key":"8583_CR48","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000097052","volume":"23","author":"K Gormley","year":"2007","unstructured":"Gormley, K., Bevan, S., & Markus, H. (2007). Polymorphisms in genes of the renin-angiotensin system and cerebral small vessel disease. Cerebrovascular Diseases,23(2\u20133), 148\u2013155.","journal-title":"Cerebrovascular Diseases"},{"issue":"3","key":"8583_CR49","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/1933719109351935","volume":"17","author":"R Goyal","year":"2010","unstructured":"Goyal, R., Goyal, D., Leitzke, A., Gheorghe, C. P., & Longo, L. D. (2010). Brain renin-angiotensin system: Fetal epigenetic programming by maternal protein restriction during pregnancy. Reproductive Sciences,17(3), 227\u2013238.","journal-title":"Reproductive Sciences"},{"issue":"9287","key":"8583_CR50","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","volume":"358","author":"Group, P. C","year":"2001","unstructured":"Group, P. C. (2001). Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. The Lancet,358(9287), 1033\u20131041.","journal-title":"The Lancet"},{"issue":"8","key":"8583_CR51","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1042\/CS20060342","volume":"112","author":"S Higuchi","year":"2007","unstructured":"Higuchi, S., Ohtsu, H., Suzuki, H., Shirai, H., Frank, G. D., & Eguchi, S. (2007). Angiotensin II signal transduction through the AT1 receptor: Novel insights into mechanisms and pathophysiology. Clinical Science,112(8), 417\u2013428.","journal-title":"Clinical Science"},{"issue":"5","key":"8583_CR52","doi-asserted-by":"publisher","first-page":"e96338","DOI":"10.1371\/journal.pone.0096338","volume":"9","author":"B Hu","year":"2014","unstructured":"Hu, B., TaoSong, J., YanQu, H., LongBi, C., ZhenHuang, X., XinLiu, X., et al. (2014). Mechanical stretch suppresses microRNA-145 expression by activating extracellular signal-regulated kinase 1\/2 and upregulating angiotensin-converting enzyme to alter vascular smooth muscle cell phenotype. PLoS ONE,9(5), e96338.","journal-title":"PLoS ONE"},{"issue":"1","key":"8583_CR53","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1177\/1470320313481838","volume":"15","author":"Y Huang","year":"2014","unstructured":"Huang, Y., Li, G., Lan, H., Zhao, G., & Huang, C. (2014). Angiotensin-converting enzyme insertion\/deletion gene polymorphisms and risk of intracerebral hemorrhage: A meta-analysis of epidemiologic studies. Journal of the Renin-Angiotensin-Aldosterone System,15(1), 32\u201338.","journal-title":"Journal of the Renin-Angiotensin-Aldosterone System"},{"key":"8583_CR54","unstructured":"Hubert, C., Houot, A.-M., Corvol, P., & Soubrier, F. (1991). Structure of the angiotensin I-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene. Journal of Biological Chemistry, 266(23), 15377-15383."},{"key":"8583_CR55","doi-asserted-by":"crossref","unstructured":"Jackson, K. L., Marques, F. Z., Nguyen-Huu, T.-P., Stevenson, E. R., Charchar, F. J., Davern, P. J., & Head, G. A. (2014). MicroRNA-181a mimic inhibits the renin-angiotensin system and attenuates hypertension in a neurogenic model of hypertension. Hypertension, 64(suppl_1), A038-A038.","DOI":"10.1161\/hyp.64.suppl_1.038"},{"key":"8583_CR56","doi-asserted-by":"crossref","unstructured":"Jacob, H. J., Lindpaintner, K., Lincoln, S. E., Kusumi, K., Bunker, R. K., Mao, Y.-P., ... Lander, E. S. (1991). Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell,67(1), 213\u2013224.","DOI":"10.1016\/0092-8674(91)90584-L"},{"key":"8583_CR57","doi-asserted-by":"crossref","unstructured":"Jeppesen, P. L., Christensen, G. L., Schneider, M., Nossent, A. Y., Jensen, H. B., Andersen, D. C., ... Sheikh, S. P. (2011). Angiotensin II type 1 receptor signalling regulates microRNA differentially in cardiac fibroblasts and myocytes. British Journal of Pharmacology,164(2), 394\u2013404.","DOI":"10.1111\/j.1476-5381.2011.01375.x"},{"key":"8583_CR58","doi-asserted-by":"crossref","unstructured":"Jiang, L., Zhou, X., Yang, H., Guan, R., Xin, Y., Wang, J., ... Wang, J. (2013). ACE2-Ang-(1-7)-Mas axis in brain: A potential target for prevention and treatment of ischemic stroke. Current Neuropharmacology,11(2), 209\u2013217.","DOI":"10.2174\/1570159X11311020007"},{"key":"8583_CR59","unstructured":"Jiang, L., Zhou, X., Yang, H., Guan, R., Xin, Y., Wang, J.,\u2026 Wang, J. (2018). Upregulation of AT1 Receptor Mediates a Pressor Effect through ROS-SAPK\/JNK Signaling in Glutamatergic Neurons of Rostral Ventrolateral Medulla in Rats with Stress-Induced Hypertension. Frontiers in physiology, 9."},{"key":"8583_CR60","doi-asserted-by":"crossref","unstructured":"Jin, W., Reddy, M. A., Chen, Z., Putta, S., Lanting, L., Kato, M., ... Tangirala, R. K. (2012). Small RNA sequencing reveals microRNAs that modulate angiotensin II effects in vascular smooth muscle cells. Journal of Biological Chemistry,287(19), 15672\u201315683.","DOI":"10.1074\/jbc.M111.322669"},{"issue":"7\u20138","key":"8583_CR61","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.cca.2010.12.022","volume":"412","author":"J Kalita","year":"2011","unstructured":"Kalita, J., Somarajan, B. I., Kumar, B., Mittal, B., & Misra, U. K. (2011). A study of ACE and ADD1 polymorphism in ischemic and hemorrhagic stroke. Clinica Chimica Acta,412(7\u20138), 642\u2013646.","journal-title":"Clinica Chimica Acta"},{"issue":"1\u20133","key":"8583_CR62","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.regpep.2009.09.001","volume":"159","author":"U Kandalam","year":"2010","unstructured":"Kandalam, U., & Clark, M. A. (2010). Angiotensin II activates JAK2\/STAT3 pathway and induces interleukin-6 production in cultured rat brainstem astrocytes. Regulatory Peptides,159(1\u20133), 110\u2013116.","journal-title":"Regulatory Peptides"},{"issue":"3","key":"8583_CR63","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/cvr\/cvp073","volume":"82","author":"Y-M Kang","year":"2009","unstructured":"Kang, Y.-M., Ma, Y., Zheng, J.-P., Elks, C., Sriramula, S., Yang, Z.-M., et al. (2009). Brain nuclear factor-kappa B activation contributes to neurohumoral excitation in angiotensin II-induced hypertension. Cardiovascular Research,82(3), 503\u2013512.","journal-title":"Cardiovascular Research"},{"issue":"5","key":"8583_CR64","doi-asserted-by":"publisher","first-page":"498","DOI":"10.4103\/0028-3886.103195","volume":"60","author":"S Kaul","year":"2012","unstructured":"Kaul, S., & Munshi, A. (2012). Genetics of ischemic stroke: Indian perspective. Neurology India,60(5), 498.","journal-title":"Neurology India"},{"key":"8583_CR65","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.yjmcc.2014.06.008","volume":"75","author":"JR Kemp","year":"2014","unstructured":"Kemp, J. R., Unal, H., Desnoyer, R., Yue, H., Bhatnagar, A., & Karnik, S. S. (2014). Angiotensin II-regulated microRNA 483-3p directly targets multiple components of the renin\u2013angiotensin system. Journal of Molecular and Cellular Cardiology,75, 25\u201339.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"issue":"7","key":"8583_CR66","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1136\/jmg.37.7.498","volume":"37","author":"M Keramatipour","year":"2000","unstructured":"Keramatipour, M., McConnell, R. S., Kirkpatrick, P., Tebbs, S., Furlong, R. A., & Rubinsztein, D. C. (2000). The ACE I allele is associated with increased risk for ruptured intracranial aneurysms. Journal of Medical Genetics,37(7), 498\u2013500.","journal-title":"Journal of Medical Genetics"},{"issue":"7","key":"8583_CR67","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.tins.2017.05.002","volume":"40","author":"BS Khakh","year":"2017","unstructured":"Khakh, B. S., Beaumont, V., Cachope, R., Munoz-Sanjuan, I., Goldman, S. A., & Grantyn, R. (2017). Unravelling and exploiting astrocyte dysfunction in Huntington\u2019s disease. Trends in Neurosciences,40(7), 422\u2013437.","journal-title":"Trends in Neurosciences"},{"issue":"5","key":"8583_CR68","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nrm1644","volume":"6","author":"VN Kim","year":"2005","unstructured":"Kim, V. N. (2005). MicroRNA biogenesis: Coordinated cropping and dicing. Nature Reviews Molecular Cell Biology,6(5), 376.","journal-title":"Nature Reviews Molecular Cell Biology"},{"issue":"7","key":"8583_CR69","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1161\/ATVBAHA.113.303134","volume":"34","author":"CW Kim","year":"2014","unstructured":"Kim, C. W., Kumar, S., Son, D. J., Jang, I.-H., Griendling, K. K., & Jo, H. (2014). Prevention of abdominal aortic aneurysm by Anti\u2013MicroRNA-712 or Anti\u2013MicroRNA-205 in angiotensin II\u2013infused mice. Arteriosclerosis, Thrombosis, and Vascular Biology,34(7), 1412\u20131421.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"8583_CR70","doi-asserted-by":"crossref","unstructured":"Kim-Mitsuyama, S., Izumi, Y., Izumiya, Y., Namba, M., Yoshida, K., Wake, R., ... Iwao, H. (2006). Dominant-negative c-Jun inhibits rat cardiac hypertrophy induced by angiotensin II and hypertension. Gene Therapy,13(4), 348.","DOI":"10.1038\/sj.gt.3302670"},{"issue":"8","key":"8583_CR71","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1161\/CIRCRESAHA.113.301282","volume":"112","author":"K Kohlstedt","year":"2013","unstructured":"Kohlstedt, K., Trouvain, C., Boettger, T., Shi, L., Fisslthaler, B., & Fleming, I. (2013). AMP-activated protein kinase regulates endothelial cell angiotensin-converting enzyme expression via p53 and the post-transcriptional regulation of microRNA-143\/145. Circulation Research,112(8), 1150\u20131158.","journal-title":"Circulation Research"},{"issue":"1","key":"8583_CR72","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0959-437X(98)80069-5","volume":"8","author":"M Kretzschmar","year":"1998","unstructured":"Kretzschmar, M., & Massagu\u00e9, J. (1998). SMADs: Mediators and regulators of TGF-\u03b2 signaling. Current Opinion in Genetics & Development,8(1), 103\u2013111.","journal-title":"Current Opinion in Genetics & Development"},{"issue":"5","key":"8583_CR73","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1161\/01.STR.27.5.852","volume":"27","author":"J Krupinski","year":"1996","unstructured":"Krupinski, J., Kumar, P., Kumar, S., & Kaluza, J. (1996). Increased expression of TGF-\u03b21 in brain tissue after ischemic stroke in humans. Stroke,27(5), 852\u2013857.","journal-title":"Stroke"},{"key":"8583_CR74","doi-asserted-by":"crossref","unstructured":"Kumar, A., Vivekanandhan, S., Srivastava, A., Tripathi, M., Padma Srivastava, M., Saini, N., ... Prasad, K. (2014). Association between angiotensin converting enzyme gene insertion\/deletion polymorphism and ischemic stroke in North Indian population: A case\u2013control study and meta-analysis. Neurological Research,36(9), 786\u2013794.","DOI":"10.1179\/1743132814Y.0000000335"},{"issue":"4","key":"8583_CR75","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1042\/CS20130420","volume":"127","author":"DW Lambert","year":"2014","unstructured":"Lambert, D. W., Lambert, L. A., Clarke, N. E., Hooper, N. M., Porter, K. E., & Turner, A. J. (2014). Angiotensin-converting enzyme 2 is subject to post-transcriptional regulation by miR-421. Clinical Science,127(4), 243\u2013249.","journal-title":"Clinical Science"},{"key":"8583_CR76","doi-asserted-by":"crossref","unstructured":"Lanz, T. V., Ding, Z., Ho, P. P., Luo, J., Agrawal, A. N., Srinagesh, H., ... Wyss-Coray, T. (2010). Angiotensin II sustains brain inflammation in mice via TGF-\u03b2. The Journal of Clinical Investigation,120(8), 2782\u20132794.","DOI":"10.1172\/JCI41709"},{"issue":"4","key":"8583_CR77","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1161\/ATVBAHA.108.181610","volume":"30","author":"B Lass\u00e8gue","year":"2010","unstructured":"Lass\u00e8gue, B., & Griendling, K. K. (2010). NADPH oxidases: Functions and pathologies in the vasculature. Arteriosclerosis, Thrombosis, and Vascular Biology,30(4), 653\u2013661.","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"20","key":"8583_CR78","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1038\/sj.emboj.7600385","volume":"23","author":"Y Lee","year":"2004","unstructured":"Lee, Y., Kim, M., Han, J., Yeom, K. H., Lee, S., Baek, S. H., et al. (2004). MicroRNA genes are transcribed by RNA polymerase II. The EMBO journal,23(20), 4051\u20134060.","journal-title":"The EMBO journal"},{"issue":"1\u20132","key":"8583_CR79","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0361-9230(93)90036-B","volume":"30","author":"Z Li","year":"1993","unstructured":"Li, Z., Bains, J. S., & Ferguson, A. V. (1993). Functional evidence that the angiotensin antagonist losartan crosses the blood-brain barrier in the rat. Brain Research Bulletin,30(1\u20132), 33\u201339.","journal-title":"Brain Research Bulletin"},{"key":"8583_CR80","doi-asserted-by":"crossref","unstructured":"Lin, H., Pan, S., Meng, L., Zhou, C., Jiang, C., Ji, Z., ... Guo, H. (2017). MicroRNA-384-mediated Herpud1 upregulation promotes angiotensin II-induced endothelial cell apoptosis. Biochemical and Biophysical Research Communications,488(3), 453\u2013460.","DOI":"10.1016\/j.bbrc.2017.05.035"},{"key":"8583_CR82","doi-asserted-by":"crossref","unstructured":"Lonn, E. M., Bosch, J., L\u00f3pez-Jaramillo, P., Zhu, J., Liu, L., Pais, P., ... Dans, A. (2016). Blood-pressure lowering in intermediate-risk persons without cardiovascular disease. New England Journal of Medicine,374(21), 2009\u20132020.","DOI":"10.1056\/NEJMoa1600175"},{"issue":"4","key":"8583_CR83","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1152\/physiol.00004.2006","volume":"21","author":"AN Lyle","year":"2006","unstructured":"Lyle, A. N., & Griendling, K. K. (2006). Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology,21(4), 269\u2013280.","journal-title":"Physiology"},{"issue":"8","key":"8583_CR84","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1080\/00207454.2017.1412962","volume":"128","author":"RG Malueka","year":"2018","unstructured":"Malueka, R. G., Dwianingsih, E. K., Sutarni, S., Bawono, R. G., Bayuangga, H. F., Gofir, A., et al. (2018). The D allele of the angiotensin-converting enzyme (ACE) insertion\/deletion (I\/D) polymorphism is associated with worse functional outcome of ischaemic stroke. International Journal of Neuroscience,128(8), 697\u2013704.","journal-title":"International Journal of Neuroscience"},{"key":"8583_CR85","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jns.2017.08.1741","volume":"381","author":"RG Malueka","year":"2017","unstructured":"Malueka, R. G., Dwianingsih, E. K., Sutarni, S., Gofir, A., & Setyopranoto, I. (2017). Association between ace gene polymorphism and functional outcome of ischemic stroke. Journal of the Neurological Sciences,381, 618.","journal-title":"Journal of the Neurological Sciences"},{"key":"8583_CR86","doi-asserted-by":"crossref","unstructured":"Markoula, S., Giannopoulos, S., Kostoulas, C., Tatsioni, A., Bouba, I., Maranis, S.,\u2026 Kyritsis, A. P. (2011). Gender association of the angiotensin-converting enzyme gene with ischaemic stroke. Journal of the Renin-Angiotensin-Aldosterone System, 12(4), 510-515.","DOI":"10.1177\/1470320310391333"},{"key":"8583_CR87","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Rodr\u00edguez, N., Posadas-Romero, C., Villarreal-Molina, T., Vallejo, M., Del-Valle-Mondrag\u00f3n, L., Ram\u00edrez-Bello, J., ... Vargas-Alarc\u00f3n, G. (2013). Single nucleotide polymorphisms of the angiotensin-converting enzyme (ACE) gene are associated with essential hypertension and increased ACE enzyme levels in Mexican individuals. PLoS ONE,8(5), e65700.","DOI":"10.1371\/journal.pone.0065700"},{"key":"8583_CR88","doi-asserted-by":"crossref","unstructured":"Matarin, M., Brown, W. M., Dena, H., Britton, A., De Vrieze, F. W., Brott, T. G., ... Chanock, S. J. (2009). Candidate gene polymorphisms for ischemic stroke. Stroke,40(11), 3436\u20133442.","DOI":"10.1161\/STROKEAHA.109.558015"},{"issue":"2","key":"8583_CR89","doi-asserted-by":"publisher","first-page":"e0211054","DOI":"10.1371\/journal.pone.0211054","volume":"14","author":"HG Mengesha","year":"2019","unstructured":"Mengesha, H. G., Petrucka, P., Spence, C., & Tafesse, T. B. (2019). Effects of angiotensin converting enzyme gene polymorphism on hypertension in Africa: A meta-analysis and systematic review. PLoS ONE,14(2), e0211054.","journal-title":"PLoS ONE"},{"issue":"2","key":"8583_CR90","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10286-018-0572-5","volume":"29","author":"AJ Miller","year":"2019","unstructured":"Miller, A. J., & Arnold, A. C. (2019). The renin\u2013angiotensin system in cardiovascular autonomic control: Recent developments and clinical implications. Clinical Autonomic Research,29(2), 231\u2013243.","journal-title":"Clinical Autonomic Research"},{"key":"8583_CR91","doi-asserted-by":"crossref","unstructured":"Moore, J. P., Vinh, A., Tuck, K. L., Sakkal, S., Krishnan, S. M., Chan, C. T., ... Kemp-Harper, B. K. (2015). M2 macrophage accumulation in the aortic wall during angiotensin II infusion in mice is associated with fibrosis, elastin loss, and elevated blood pressure. American Journal of Physiology-Heart and Circulatory Physiology,309(5), H906\u2013H917.","DOI":"10.1152\/ajpheart.00821.2014"},{"issue":"2","key":"8583_CR92","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.gene.2014.11.015","volume":"555","author":"A Munshi","year":"2015","unstructured":"Munshi, A., Das, S., & Kaul, S. (2015). Genetic determinants in ischaemic stroke subtypes: Seven year findings and a review. Gene,555(2), 250\u2013259.","journal-title":"Gene"},{"issue":"2","key":"8583_CR93","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4103\/0028-3886.63780","volume":"58","author":"A Munshi","year":"2010","unstructured":"Munshi, A., & Kaul, S. (2010). Genetic basis of stroke: An overview. Neurology India,58(2), 185.","journal-title":"Neurology India"},{"issue":"1\u20132","key":"8583_CR94","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jns.2008.05.017","volume":"272","author":"A Munshi","year":"2008","unstructured":"Munshi, A., Sultana, S., Kaul, S., Reddy, B. P., Alladi, S., & Jyothy, A. (2008). Angiotensin-converting enzyme insertion\/deletion polymorphism and the risk of ischemic stroke in a South Indian population. Journal of the Neurological Sciences,272(1\u20132), 132\u2013135.","journal-title":"Journal of the Neurological Sciences"},{"issue":"12","key":"8583_CR95","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11906-016-0696-8","volume":"18","author":"M Nemecz","year":"2016","unstructured":"Nemecz, M., Alexandru, N., Tanko, G., & Georgescu, A. (2016). Role of microRNA in endothelial dysfunction and hypertension. Current Hypertension Reports,18(12), 87.","journal-title":"Current Hypertension Reports"},{"issue":"5","key":"8583_CR96","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3892\/br.2013.144","volume":"1","author":"Q Ning","year":"2013","unstructured":"Ning, Q., & Jiang, X. (2013). Angiotensin II upregulated the expression of microRNA-224 but not microRNA-21 in adult rat cardiac fibroblasts. Biomedical reports,1(5), 776\u2013780.","journal-title":"Biomedical reports"},{"key":"8583_CR97","doi-asserted-by":"crossref","unstructured":"Ohkuma, T., Jun, M., Rodgers, A., Cooper, M. E., Glasziou, P., Hamet, P., ... Neal, B. (2019). Acute increases in serum creatinine after starting angiotensin-converting enzyme inhibitor-based therapy and effects of its continuation on major clinical outcomes in Type 2 diabetes mellitus: The ADVANCE Trial. Hypertension,73(1), 84\u201391.","DOI":"10.1161\/HYPERTENSIONAHA.118.12060"},{"issue":"1","key":"8583_CR98","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3171\/jns.2005.103.1.0092","volume":"103","author":"H Pannu","year":"2005","unstructured":"Pannu, H., Kim, D. H., Seaman, C. R., Van Ginhoven, G., Shete, S., & Milewicz, D. M. (2005). Lack of an association between the angiotensin-converting enzyme insertion\/deletion polymorphism and intracranial aneurysms in a Caucasian population in the United States. Journal of Neurosurgery,103(1), 92\u201396.","journal-title":"Journal of Neurosurgery"},{"issue":"11","key":"8583_CR99","doi-asserted-by":"publisher","first-page":"e3691","DOI":"10.1371\/journal.pone.0003691","volume":"3","author":"G Peck","year":"2008","unstructured":"Peck, G., Smeeth, L., Whittaker, J., Casas, J. P., Hingorani, A., & Sharma, P. (2008). The genetics of primary haemorrhagic stroke, subarachnoid haemorrhage and ruptured intracranial aneurysms in adults. PLoS ONE,3(11), e3691.","journal-title":"PLoS ONE"},{"issue":"1","key":"8583_CR100","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1161\/HYPERTENSIONAHA.115.05278","volume":"66","author":"RA Pe\u00f1a-Silva","year":"2015","unstructured":"Pe\u00f1a-Silva, R. A., & Heistad, D. D. (2015). Stages in discovery: ACE2 and stroke. Hypertension,66(1), 15.","journal-title":"Hypertension"},{"issue":"5","key":"8583_CR101","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1600-0404.2006.00672.x","volume":"114","author":"J Pera","year":"2006","unstructured":"Pera, J., Slowik, A., Dziedzic, T., Wloch, D., & Szczudlik, A. (2006). ACE I\/D polymorphism in different etiologies of ischemic stroke. Acta Neurologica Scandinavica,114(5), 320\u2013322.","journal-title":"Acta Neurologica Scandinavica"},{"key":"8583_CR102","unstructured":"Peterson, M. C. (2005). Circulating transforming growth factor \u00df-1: A partial molecular explanation for associations between hypertension, diabetes, obesity, smoking and human disease involving fibrosis. Medical Science Monitor, 11(7), RA229\u2013RA232."},{"key":"8583_CR103","doi-asserted-by":"crossref","unstructured":"Peterson, J. R., Burmeister, M. A., Tian, X., Zhou, Y., Guruju, M. R., Stupinski, J. A., ... Davisson, R. L. (2009). Genetic silencing of Nox2 and Nox4 reveals differential roles of these NADPH oxidase homologues in the vasopressor and dipsogenic effects of brain angiotensin II. Hypertension,54(5), 1106\u20131114.","DOI":"10.1161\/HYPERTENSIONAHA.109.140087"},{"key":"8583_CR104","doi-asserted-by":"crossref","unstructured":"Prabhakar, P., De, T., Nagaraja, D., & Christopher, R. (2014). Angiotensin-converting enzyme gene insertion\/deletion polymorphism and small vessel cerebral stroke in Indian population. International Journal of Vascular Medicine, 1\u20134.","DOI":"10.1155\/2014\/305309"},{"issue":"1","key":"8583_CR105","first-page":"1","volume":"3","author":"LM Ruilope","year":"2007","unstructured":"Ruilope, L. M., Red\u00f3n, J., & Schmieder, R. (2007). Cardiovascular risk reduction by reversing endothelial dysfunction: ARBs, ACE inhibitors, or both? Expectations from the ONTARGET Trial Programme. Vascular Health and Risk Management,3(1), 1.","journal-title":"Vascular Health and Risk Management"},{"issue":"3\u20134","key":"8583_CR106","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s10571-005-4011-5","volume":"25","author":"JM Saavedra","year":"2005","unstructured":"Saavedra, J. M. (2005). Brain angiotensin II: New developments, unanswered questions and therapeutic opportunities. Cellular and Molecular Neurobiology,25(3\u20134), 485\u2013512.","journal-title":"Cellular and Molecular Neurobiology"},{"key":"8583_CR107","doi-asserted-by":"crossref","unstructured":"Sacco, R. L., Kasner, S. E., Broderick, J. P., Caplan, L. R., Connors, J., Culebras, A., \u2026 Higashida, R. T. (2013). An updated definition of stroke for the 21st century: A statement for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke, 44(7), 2064\u20132089.","DOI":"10.1161\/STR.0b013e318296aeca"},{"issue":"1","key":"8583_CR108","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1006\/jmcc.2000.1272","volume":"33","author":"Y Saito","year":"2001","unstructured":"Saito, Y., & Berk, B. C. (2001). Transactivation: A novel signaling pathway from angiotensin II to tyrosine kinase receptors. Journal of Molecular and Cellular Cardiology,33(1), 3\u20137.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"8583_CR109","doi-asserted-by":"crossref","unstructured":"Santos, R. A., de Silva, A. C. S., Maric, C., Silva, D. M., Machado, R. P., de Buhr, I., \u2026 Bader, M. (2003). Angiotensin-(1\u20137) is an endogenous ligand for the G protein-coupled receptor Mas. Proceedings of the National Academy of Sciences USA, 100(14), 8258\u20138263.","DOI":"10.1073\/pnas.1432869100"},{"issue":"9","key":"8583_CR110","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/01.RES.0000223145.74217.e7","volume":"98","author":"F Sayed-Tabatabaei","year":"2006","unstructured":"Sayed-Tabatabaei, F., Oostra, B., Isaacs, A., Van Duijn, C., & Witteman, J. (2006). ACE polymorphisms. Circulation Research,98(9), 1123\u20131133.","journal-title":"Circulation Research"},{"key":"8583_CR111","doi-asserted-by":"crossref","unstructured":"Schrader, J., L\u00fcders, S., Kulschewski, A., Hammersen, F., Plate, K., Berger, J. r., \u2026 Group, M. S. (2005). Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention: Principal results of a prospective randomized controlled study (MOSES). Stroke, 36(6), 1218\u20131224.","DOI":"10.1161\/01.STR.0000166048.35740.a9"},{"issue":"1","key":"8583_CR112","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/14728222.2017.1265505","volume":"21","author":"NM Sharma","year":"2017","unstructured":"Sharma, N. M., & Patel, K. P. (2017). Post-translational regulation of neuronal nitric oxide synthase: Implications for sympathoexcitatory states. Expert opinion on therapeutic targets,21(1), 11\u201322.","journal-title":"Expert opinion on therapeutic targets"},{"issue":"2","key":"8583_CR113","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11906-010-0091-9","volume":"12","author":"DA Sica","year":"2010","unstructured":"Sica, D. A. (2010). The evolution of renin-angiotensin blockade: Angiotensin-converting enzyme inhibitors as the starting point. Current Hypertension Reports,12(2), 67\u201373.","journal-title":"Current Hypertension Reports"},{"key":"8583_CR114","first-page":"245","volume-title":"A Review of antihypertensive drugs and choosing the right antihypertensive for recurrent stroke prevention hypertension and stroke","author":"DA Sica","year":"2016","unstructured":"Sica, D. A. (2016). A Review of antihypertensive drugs and choosing the right antihypertensive for recurrent stroke prevention hypertension and stroke (pp. 245\u2013257). New York: Springer."},{"key":"8583_CR115","doi-asserted-by":"crossref","unstructured":"Slowik, A., Borratynska, A., Pera, J., Betlej, M., Dziedzic, T., Krzyszkowski, T., \u2026 Szczudlik, A. (2004). II genotype of the angiotensin-converting enzyme gene increases the risk for subarachnoid hemorrhage from ruptured aneurysm. Stroke, 35(7), 1594\u20131597.","DOI":"10.1161\/01.STR.0000131655.45227.f7"},{"issue":"12","key":"8583_CR116","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1097\/00004872-199917120-00006","volume":"17","author":"JS Smeda","year":"1999","unstructured":"Smeda, J. S., VanVliet, B. N., & King, S. R. (1999). Stroke-prone spontaneously hypertensive rats lose their ability to auto-regulate cerebral blood flow prior to stroke. Journal of Hypertension,17(12), 1697\u20131705.","journal-title":"Journal of Hypertension"},{"issue":"3","key":"8583_CR117","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/cvr\/cvr242","volume":"92","author":"S Sriramula","year":"2011","unstructured":"Sriramula, S., Cardinale, J. P., Lazartigues, E., & Francis, J. (2011). ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension. Cardiovascular Research,92(3), 401\u2013408.","journal-title":"Cardiovascular Research"},{"issue":"3","key":"8583_CR118","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1161\/HYPERTENSIONAHA.114.04691","volume":"65","author":"S Sriramula","year":"2015","unstructured":"Sriramula, S., Xia, H., Xu, P., & Lazartigues, E. (2015). Brain-targeted ACE2 overexpression attenuates neurogenic hypertension by inhibiting COX mediated inflammation. Hypertension,65(3), 577.","journal-title":"Hypertension"},{"key":"8583_CR119","doi-asserted-by":"crossref","unstructured":"Staals\u00f8, J. M., Nielsen, M., Edsen, T., Koefoed, P., Springborg, J. B., Moltke, F. B., \u2026 Olsen, N. V. (2011). Common variants of the ACE gene and aneurysmal subarachnoid hemorrhage in a Danish population: A case-control study. Journal of Neurosurgical Anesthesiology, 23(4), 304\u2013309.","DOI":"10.1097\/ANA.0b013e318225c979"},{"key":"8583_CR120","doi-asserted-by":"crossref","unstructured":"Sun, Y., Liu, Y., Watts, L. T., Sun, Q., Zhong, Z., Yang, G.-Y., & Bian, L. (2014). Correction: Genetic Associations of Angiotensin-Converting Enzyme with Primary Intracerebral Hemorrhage: A Meta-analysis. PloS one, 9(1).","DOI":"10.1371\/annotation\/7f2d85e0-c41a-40cf-80e1-6ce4b0470eff"},{"issue":"5","key":"8583_CR121","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s40256-016-0173-4","volume":"16","author":"S Taddei","year":"2016","unstructured":"Taddei, S., & Bortolotto, L. (2016). Unraveling the pivotal role of bradykinin in ACE inhibitor activity. American Journal of Cardiovascular Drugs,16(5), 309\u2013321.","journal-title":"American Journal of Cardiovascular Drugs"},{"issue":"1\u20132","key":"8583_CR122","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jns.2009.06.016","volume":"285","author":"N Tascilar","year":"2009","unstructured":"Tascilar, N., Dursun, A., Ankarali, H., Mungan, G., Ekem, S., & Baris, S. (2009). Angiotensin-converting enzyme insertion\/deletion polymorphism has no effect on the risk of atherosclerotic stroke or hypertension. Journal of the Neurological Sciences,285(1\u20132), 137\u2013141.","journal-title":"Journal of the Neurological Sciences"},{"issue":"5","key":"8583_CR123","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.tibs.2004.03.008","volume":"29","author":"P ten Dijke","year":"2004","unstructured":"ten Dijke, P., & Hill, C. S. (2004). New insights into TGF-\u03b2\u2013Smad signalling. Trends in Biochemical Sciences,29(5), 265\u2013273.","journal-title":"Trends in Biochemical Sciences"},{"key":"8583_CR124","doi-asserted-by":"crossref","unstructured":"Tsuda, K. (2012). Renin-angiotensin system and sympathetic neurotransmitter release in the central nervous system of hypertension. International journal of hypertension, 2012.","DOI":"10.1155\/2012\/474870"},{"issue":"2","key":"8583_CR125","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jocn.2005.08.005","volume":"13","author":"N Tuncer","year":"2006","unstructured":"Tuncer, N., Tuglular, S., K\u0131l\u0131\u00e7, G., Sazc\u0131, A., Us, \u00d6., & Kara, \u0130. (2006). Evaluation of the angiotensin-converting enzyme insertion\/deletion polymorphism and the risk of ischaemic stroke. Journal of Clinical Neuroscience,13(2), 224\u2013227.","journal-title":"Journal of Clinical Neuroscience"},{"issue":"6","key":"8583_CR126","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0008-6363(96)00170-8","volume":"32","author":"E Villard","year":"1996","unstructured":"Villard, E., & Soubrier, F. (1996). Molecular biology and genetics of the angiotensin-I-converting enzyme: Potential implications in cardiovascular diseases. Cardiovascular Research,32(6), 999\u20131007.","journal-title":"Cardiovascular Research"},{"issue":"6","key":"8583_CR127","first-page":"1268","volume":"58","author":"E Villard","year":"1996","unstructured":"Villard, E., Tiret, L., Visvikis, S., Rakotovao, R., Cambien, F., & Soubrier, F. (1996). Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two-QTL segregation-linkage analysis. American Journal of Human Genetics,58(6), 1268.","journal-title":"American Journal of Human Genetics"},{"issue":"8","key":"8583_CR128","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1097\/01.ALC.0000137299.04112.C2","volume":"28","author":"X Wang","year":"2004","unstructured":"Wang, X., & Abdel-Rahman, A. A. (2004). An association between ethanol-evoked enhancement of c-jun gene expression in the nucleus tractus solitarius and the attenuation of baroreflexes. Alcoholism: Clinical and Experimental Research,28(8), 1264\u20131272.","journal-title":"Alcoholism: Clinical and Experimental Research"},{"key":"8583_CR129","doi-asserted-by":"crossref","unstructured":"Wei, L. K., Au, A., Menon, S., Griffiths, L. R., Kooi, C. W., Irene, L., \u2026 Hassan, M. R. A. (2017). Polymorphisms of MTHFR, eNOS, ACE, AGT, ApoE, PON1, PDE4D, and ischemic stroke: Meta-analysis. Journal of Stroke and Cerebrovascular Diseases, 26(11), 2482\u20132493.","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.05.048"},{"issue":"6","key":"8583_CR130","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1007\/s00125-002-0843-4","volume":"45","author":"C Weigert","year":"2002","unstructured":"Weigert, C., Brodbeck, K., Klopfer, K., H\u00e4ring, H., & Schleicher, E. (2002). Angiotensin II induces human TGF-\u03b21 promoter activation: Similarity to hyperglycaemia. Diabetologia,45(6), 890\u2013898.","journal-title":"Diabetologia"},{"issue":"S9","key":"8583_CR131","doi-asserted-by":"publisher","first-page":"205S","DOI":"10.1016\/S0895-7061(99)00103-X","volume":"12","author":"MR Weir","year":"1999","unstructured":"Weir, M. R., & Dzau, V. J. (1999). The renin-angiotensin-aldosterone system: A specific target for hypertension management. American Journal of Hypertension,12(S9), 205S\u2013213S.","journal-title":"American Journal of Hypertension"},{"issue":"10","key":"8583_CR132","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1038\/ajh.2011.116","volume":"24","author":"W-H Wu","year":"2011","unstructured":"Wu, W.-H., Hu, C.-P., Chen, X.-P., Zhang, W.-F., Li, X.-W., Xiong, X.-M., et al. (2011). MicroRNA-130a mediates proliferation of vascular smooth muscle cells in hypertension. American Journal of Hypertension,24(10), 1087\u20131093.","journal-title":"American Journal of Hypertension"},{"key":"8583_CR81","doi-asserted-by":"crossref","unstructured":"Yang, L.-x., Liu, G., Zhu, G.-f., Liu, H., Guo, R.-w., Qi, F., & Zou, J.-h. (2014). MicroRNA-155 inhibits angiotensin II-induced vascular smooth muscle cell proliferation. Journal of the Renin-Angiotensin-Aldosterone System, 15(2), 109-116.","DOI":"10.1177\/1470320313503693"},{"issue":"3","key":"8583_CR133","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1161\/CIRCRESAHA.110.228437","volume":"108","author":"Y Yang","year":"2011","unstructured":"Yang, Y., Ago, T., Zhai, P., Abdellatif, M., & Sadoshima, J. (2011). Thioredoxin 1 negatively regulates angiotensin II\u2013induced cardiac hypertrophy through upregulation of miR-98\/let-7. Circulation Research,108(3), 305\u2013313.","journal-title":"Circulation Research"},{"key":"8583_CR134","doi-asserted-by":"crossref","unstructured":"Yang, X., Long, L., Southwood, M., Rudarakanchana, N., Upton, P. D., Jeffery, T. K., \u2026 Morrell, N. W. (2005). Dysfunctional Smad signaling contributes to abnormal smooth muscle cell proliferation in familial pulmonary arterial hypertension. Circulation Research, 96(10), 1053\u20131063.","DOI":"10.1161\/01.RES.0000166926.54293.68"},{"key":"8583_CR135","doi-asserted-by":"crossref","unstructured":"Yang, Y., Zhou, Y., Cao, Z., Tong, X. Z., Xie, H. Q., Luo, T., \u2026 Wang, H. Q. (2016). miR-155 functions downstream of angiotensin II receptor subtype 1 and calcineurin to regulate cardiac hypertrophy. Experimental and Therapeutic Medicine, 12(3), 1556\u20131562.","DOI":"10.3892\/etm.2016.3506"},{"key":"8583_CR136","doi-asserted-by":"crossref","unstructured":"Yazawa, H., Miyachi, M., Furukawa, M., Takahashi, K., Takatsu, M., Tsuboi, K., \u2026 Kato, Y. (2011). Angiotensin-converting enzyme inhibition promotes coronary angiogenesis in the failing heart of Dahl salt-sensitive hypertensive rats. Journal of Cardiac Failure, 17(12), 1041\u20131050.","DOI":"10.1016\/j.cardfail.2011.09.002"},{"issue":"4","key":"8583_CR137","doi-asserted-by":"publisher","first-page":"C857","DOI":"10.1152\/ajpcell.00313.2009","volume":"298","author":"J-X Yin","year":"2010","unstructured":"Yin, J.-X., Yang, R.-F., Li, S., Renshaw, A. O., Li, Y.-L., Schultz, H. D., et al. (2010). Mitochondria-produced superoxide mediates angiotensin II-induced inhibition of neuronal potassium current. American Journal of Physiology-Cell Physiology,298(4), C857\u2013C865.","journal-title":"American Journal of Physiology-Cell Physiology"},{"issue":"3","key":"8583_CR138","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJM200001203420301","volume":"342","author":"S Yusuf","year":"2000","unstructured":"Yusuf, S., Sleight, P., Pogue, J. F., Bosch, J., Davies, R., & Dagenais, G. (2000). Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The New England Journal of Medicine,342(3), 145\u2013153.","journal-title":"The New England Journal of Medicine"},{"issue":"5","key":"8583_CR139","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/mt.2014.25","volume":"22","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y., Huang, X.-R., Wei, L.-H., Chung, A. C., Yu, C.-M., & Lan, H.-Y. (2014). miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-\u03b2\/Smad3 signaling. Molecular Therapy,22(5), 974\u2013985.","journal-title":"Molecular Therapy"},{"issue":"10","key":"8583_CR140","doi-asserted-by":"publisher","first-page":"e46495","DOI":"10.1371\/journal.pone.0046495","volume":"7","author":"Z Zhang","year":"2012","unstructured":"Zhang, Z., Xu, G., Liu, D., Fan, X., Zhu, W., & Liu, X. (2012). Angiotensin-converting enzyme insertion\/deletion polymorphism contributes to ischemic stroke risk: A meta-analysis of 50 case-control studies. PLoS ONE,7(10), e46495.","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"8583_CR141","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jns.2014.07.023","volume":"345","author":"J Zhao","year":"2014","unstructured":"Zhao, J., Qin, X., Li, S., & Zeng, Z. (2014). Association between the ACE I\/D polymorphism and risk of ischemic stroke: An updated meta-analysis of 47,026 subjects from 105 case\u2013control studies. Journal of the Neurological Sciences,345(1\u20132), 37\u201347.","journal-title":"Journal of the Neurological Sciences"},{"key":"8583_CR142","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Wu, J., Zhang, M., Zhou, M., Xu, F., Zhu, X. ,\u2026 Yun, S. (2017). Angiotensin II induces calcium\/calcineurin signaling and podocyte injury by downregulating microRNA-30 family members. Journal of Molecular Medicine, 95(8), 887\u2013898.","DOI":"10.1007\/s00109-017-1547-z"},{"key":"8583_CR143","doi-asserted-by":"crossref","unstructured":"Zheng, L., Xu, C.-C., Chen, W.-D., Shen, W.-L., Ruan, C.-C., Zhu, L.-M., \u2026 Gao, P.-J. (2010). MicroRNA-155 regulates angiotensin II type 1 receptor expression and phenotypic differentiation in vascular adventitial fibroblasts. Biochemical and Biophysical Research Communications, 400(4), 483\u2013488.","DOI":"10.1016\/j.bbrc.2010.08.067"},{"key":"8583_CR144","doi-asserted-by":"crossref","unstructured":"Zhu, N., Zhang, D., Chen, S., Liu, X., Lin, L., Huang, X., \u2026 Yuan, W. (2011). Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration. Atherosclerosis, 215(2), 286\u2013293.","DOI":"10.1016\/j.atherosclerosis.2010.12.024"},{"issue":"11","key":"8583_CR145","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1161\/01.RES.0000043501.47934.FA","volume":"91","author":"MC Zimmerman","year":"2002","unstructured":"Zimmerman, M. C., Lazartigues, E., Lang, J. A., Sinnayah, P., Ahmad, I. M., Spitz, D. R., et al. (2002). Superoxide mediates the actions of angiotensin II in the central nervous system. Circulation Research,91(11), 1038\u20131045.","journal-title":"Circulation Research"},{"issue":"2","key":"8583_CR146","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1161\/01.RES.0000135483.12297.e4","volume":"95","author":"MC Zimmerman","year":"2004","unstructured":"Zimmerman, M. C., Lazartigues, E., Sharma, R. V., & Davisson, R. L. (2004). Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circulation Research,95(2), 210\u2013216.","journal-title":"Circulation Research"}],"container-title":["NeuroMolecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-019-08583-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12017-019-08583-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12017-019-08583-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T18:08:37Z","timestamp":1665166117000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12017-019-08583-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,4]]},"references-count":146,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["8583"],"URL":"https:\/\/doi.org\/10.1007\/s12017-019-08583-1","relation":{},"ISSN":["1535-1084","1559-1174"],"issn-type":[{"value":"1535-1084","type":"print"},{"value":"1559-1174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,4]]},"assertion":[{"value":"19 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}